The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Bristol-Myers Squibb Co

NYSE: BMY
Last

(U.S.) $53.55

Today's change-1.04 -1.91%
Updated February 21 2:25 PM EST. Delayed by at least 15 minutes.
 

Bristol-Myers Squibb Co

NYSE: BMY
Last

(U.S.) $53.55

Today's change-1.04 -1.91%
Updated February 21 2:25 PM EST. Delayed by at least 15 minutes.

Bristol-Myers Squibb Co down (U.S.)$1.04

Bristol-Myers Squibb Co is sharply lower today, dropping (U.S.)$1.04 or 1.91% to (U.S.)$53.55. Over the last five days, shares have lost 0.30% and are down 8.37% for the last year to date. This security has underperformed the S&P 500 by 39.27% during the last year.

Key company metrics

  • Open(U.S.) $54.41
  • Previous close(U.S.) $54.59
  • High(U.S.) $54.45
  • Low(U.S.) $53.41
  • Bid / Ask(U.S.) $53.55 / (U.S.) $53.56
  • YTD % change-8.37%
  • Volume8,257,701
  • Average volume (10-day)10,594,535
  • Average volume (1-month)15,596,923
  • Average volume (3-month)12,303,925
  • 52-week range(U.S.) $46.01 to (U.S.) $77.12
  • Beta1.06
  • Trailing P/E20.18×
  • P/E 1 year forward19.44×
  • Forward PEG1.36×
  • Indicated annual dividend(U.S.) $1.56
  • Dividend yield2.91%
  • Trailing EPS(U.S.) $2.65
Updated February 21 2:25 PM EST. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue5,2434,9224,8714,391
Total other revenue--------
Total revenue5,2434,9224,8714,391
Gross profit3,8603,6173,6693,343
Total cost of revenue1,3831,3051,2021,048
Total operating expense4,1153,3693,2102,741
Selling / general / administrative1,4611,1441,2381,068
Research & development1,4001,1381,2661,136
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)11-60-329-257
Other operating expenses, total-140-158-167-254
Operating income1,1281,5531,6611,650
Interest income (expense), net non-operating-40-42-42-43
Gain (loss) on sale of assets--------
Other--------
Income before tax1,0861,5591,6151,655
Income after tax8981,2151,1881,206
Income tax, total188344427449
Net income8941,2021,1661,195
Total adjustments to net income--------
Net income before extra. items8941,2021,1661,195
Minority interest-4-13-22-11
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items8941,2021,1661,195
Inc. avail. to common incl. extra. items8941,2021,1661,195
Diluted net income8941,2021,1661,195
Dilution adjustment--------
Diluted weighted average shares1,6801,6791,6791,680
Diluted EPS excluding extraordinary itemsvalue per share0.530.720.690.71
Dividends per sharevalue per share0.380.380.380.38
Diluted normalized EPSvalue per share0.540.690.550.60